To this end, Rgs5 loss- (Rgs5KO) (9) and gain-of-function (Rgs5hi) pancreatic neuroendocrine tumors (PNET, RIP1-Tag5) were established (Supplemental Figure 1, B and C). This evidence concerns the gene RGS5 and pancreatic neuroendocrine tumor.